Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patients

Background: With the availability of direct acting antiviral treatment for hepatitis C (HCV), HIV and HCV co-infected patients show comparable treatment responses to HCV-monoinfected patients. An 8-week course of sofosbuvir/ledipasvir (SOF/LDV) is highly effective for the treatment of HCV genotype 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogbuagu, Onyema, Hao, Ritche, Virata, Michael, Villanueva, Merceditas S., Malinis, Maricar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171717/
https://www.ncbi.nlm.nih.gov/pubmed/30344999
http://dx.doi.org/10.12688/f1000research.11397.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171717/
https://www.ncbi.nlm.nih.gov/pubmed/30344999
http://dx.doi.org/10.12688/f1000research.11397.2

Ejemplares similares